• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2021 Fiscal Year Research-status Report

Ligand-free hepatocyte-targeting of nanomedicines by selective stealth coating of liver reticuloendothelial system scavenger cells

Research Project

Project/Area Number 21K18062
Research InstitutionKawasaki Institute of Industrial Promotion Innovation Center of NanoMedicine

Principal Investigator

ディリサラ アンジャネユル  公益財団法人川崎市産業振興財団(ナノ医療イノベーションセンター), ナノ医療イノベーションセンター, 研究員 (70794353)

Project Period (FY) 2021-04-01 – 2023-03-31
KeywordsLiver stealth coating / Hepatocyte targeting / Gene delivery
Outline of Annual Research Achievements

The luciferase-encoding mRNA encapsulated cationic (lipid to mRNA ratio 5:1, charge +52 mV, size 155 nm) and anionic (lipid to mRNA ratio 1:2, charge -30 mV, size 221 nm) mRNA-lipoplexes were prepared by different coating amounts of the mRNA onto liposomes composed of DOTMA and DOPE. Prior stealth coating of the liver sinusoidal RES wall with two-arm-PEG-Oligo(L-Lysine) substantially enhanced the luciferase expression (14.1-fold increase) of anionic liposome in the liver compared to without liver coating. Similarly, PEG coating to the liver scavenger cell wall augmented the luciferase expression in the liver up to 3.6-fold compared to without coating. Based on these results, the applicant will choose anionic mRNA-lipoplex for future liver-directed therapeutic applications.

Current Status of Research Progress
Current Status of Research Progress

2: Research has progressed on the whole more than it was originally planned.

Reason

We have optimized the best-in-class mRNA-lipoplex carrier for mRNA introduction into the liver using the mRNA-encoding reporter protein, luciferase, using a bioluminescence assay.

Strategy for Future Research Activity

Rather than developing new carriers for mRNA delivery, the applicant will focus on relocating the existed mRNA carriers from the liver scavenger cells, liver sinusoidal endothelial cells, and Kupffer cells to the parenchymal hepatocytes without integrating complicated structural functionalities such as introducing surface ligands, charge and size modulation. In the future, such hepatocyte-selective protein expression will be exploited to develop a cure for chronic hepatitis B by destroying the virus's persistent covalently closed circular (ccc)DNA using a gene-editing tool, clustered regularly interspersed short palindromic repeats (CRISPR)/CRISPR-associated protein 9.

Causes of Carryover

The applicant will purchase fluorescent dyes for labeling the mRNA-encapsulated liposome and two-arm-PEG-Oligo(L-Lysine) for tracking their distribution in the body using real-time in vivo confocal microscopy. The applicant will also purchase the experimental mice for evaluating organ- and cell-specific delivery of mRNA-liposomes with and without liver stealth coating using flow cytometry and histological examination.

  • Research Products

    (4 results)

All 2022 2021

All Journal Article (3 results) (of which Int'l Joint Research: 3 results,  Peer Reviewed: 3 results) Patent(Industrial Property Rights) (1 results) (of which Overseas: 1 results)

  • [Journal Article] Effective mRNA Protection by Poly(L‐ornithine) Synergizes with Endosomal Escape Functionality of a Charge‐Conversion Polymer toward Maximizing mRNA Introduction Efficiency2022

    • Author(s)
      Dirisala Anjaneyulu、Uchida Satoshi、Li Junjie、Van Guyse Joachim F. R.、Hayashi Kotaro、Vummaleti Sai V. C.、Kaur Sarandeep、Mochida Yuki、Fukushima Shigeto、Kataoka Kazunori
    • Journal Title

      Macromolecular Rapid Communications

      Volume: not determined yet Pages: 2100754~2100754

    • DOI

      10.1002/marc.202100754

    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Bridging mRNA and Polycation Using RNA Oligonucleotide Derivatives Improves the Robustness of Polyplex Micelles for Efficient mRNA Delivery2021

    • Author(s)
      Yoshinaga Naoto、Uchida Satoshi、Dirisala Anjaneyulu、Naito Mitsuru、Koji Kyoko、Osada Kensuke、Cabral Horacio、Kataoka Kazunori
    • Journal Title

      Advanced Healthcare Materials

      Volume: 11 Pages: 2102016~2102016

    • DOI

      10.1002/adhm.202102016

    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Enzymatically Transformable Polymersome‐Based Nanotherapeutics to Eliminate Minimal Relapsable Cancer2021

    • Author(s)
      Li Junjie、Ge Zhishen、Toh Kazuko、Liu Xueying、Dirisala Anjaneyulu、Ke Wendong、Wen Panyue、Zhou Hang、Wang Zheng、Xiao Shiyan、Van Guyse Joachim F. R.、Tockary Theofilus A.、Xie Jinbing、Gonzalez‐Carter Daniel、Kinoh Hiroaki、Uchida Satoshi、Anraku Yasutaka、Kataoka Kazunori
    • Journal Title

      Advanced Materials

      Volume: 33 Pages: 2105254~2105254

    • DOI

      10.1002/adma.202105254

    • Peer Reviewed / Int'l Joint Research
  • [Patent(Industrial Property Rights)] 複合体、医薬、癌治療剤、キット及び結合体2021

    • Inventor(s)
      NISHIYAMA Nobuhiro et al.,
    • Industrial Property Rights Holder
      NISHIYAMA Nobuhiro et al.,
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      1
    • Overseas

URL: 

Published: 2022-12-28  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi